Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.
The da Vinci robotic surgery maker is now forecasting a 1.7 percentage point gross margin headwind from newly implemented and expected trade barriers, primarily driven by escalating US-China tariffs.
Key Takeaways
Tariff costs will increase through 2025, driven by Chinese and US import duties.
Intuitive Surgical is bracing for a $165m hit to its 2025 cost of sales as rising global tariffs look set...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
